...echo has a ton of potential if FDA approved, however they are having issues behind closed doors...just as their competition has had bringing non-invasive blood sugar monitoring techniques to production. The challenge they are facing right now is the precision of the monitor. Apparently the reading is not as exact as the FDA wants.
If there is another delay or denial, we will see sub $1...imo Do your DD..ECTE is being pumped all over the board right now. Uri Landesman has binded interest in pumping this stock. Platinum Partners ownes 1% of the total outstanding shares of this organization. Of course he is going to pump it.